RNA Pol II inhibitor Therapy(Hamlet BioPharma)

N/A

Report date: 2024/03/20 15:14:42

Base Information

Drug NameRNA Pol II inhibitor Therapy(Hamlet BioPharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHamlet BioPharma AB
China Registration ClassN/A

Develop Information

Active CompaniesHamlet BioPharma AB
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A